289 related articles for article (PubMed ID: 3261136)
1. Transformation of cutaneous T cell lymphoma to large cell lymphoma. A clinicopathologic and immunologic study.
Salhany KE; Cousar JB; Greer JP; Casey TT; Fields JP; Collins RD
Am J Pathol; 1988 Aug; 132(2):265-77. PubMed ID: 3261136
[TBL] [Abstract][Full Text] [Related]
2. Histologic and immunophenotypic features prior to transformation in patients with transformed cutaneous T-cell lymphoma: is CD25 expression in skin biopsy samples predictive of large cell transformation in cutaneous T-cell lymphoma?
Stefanato CM; Tallini G; Crotty PL
Am J Dermatopathol; 1998 Feb; 20(1):1-6. PubMed ID: 9504661
[TBL] [Abstract][Full Text] [Related]
3. Clinical features associated with transformation of cerebriform T-cell lymphoma to a large cell process.
Greer JP; Salhany KE; Cousar JB; Fields JP; King LE; Graber SE; Flexner JM; Stein RS; Collins RD
Hematol Oncol; 1990; 8(4):215-27. PubMed ID: 2210690
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
[TBL] [Abstract][Full Text] [Related]
5. Extracutaneous transformation into a high-grade lymphoma: a potential pitfall in the management of patients with Sézary syndrome.
Michaelis S; Kazakov DV; Burg G; Dummer R; Kempf W
Int J Dermatol; 2006 Mar; 45(3):277-9. PubMed ID: 16533228
[TBL] [Abstract][Full Text] [Related]
6. Lymphomatoid papulosis expresses immunophenotypes associated with T cell lymphoma but not inflammation.
Wood GS; Strickler JG; Deneau DG; Egbert B; Warnke RA
J Am Acad Dermatol; 1986 Sep; 15(3):444-58. PubMed ID: 3489740
[TBL] [Abstract][Full Text] [Related]
7. Blastic marginal zone lymphoma: a clinical and pathological study of 8 cases and review of the literature.
Magro CM; Yang A; Fraga G
Am J Dermatopathol; 2013 May; 35(3):319-26. PubMed ID: 23190506
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
9. Peripheral T-cell lymphoma: aggressive disease with heterogeneous immunotypes.
Grogan TM; Fielder K; Rangel C; Jolley CJ; Wirt DP; Hicks MJ; Miller TP; Brooks R; Greenberg B; Jones S
Am J Clin Pathol; 1985 Mar; 83(3):279-88. PubMed ID: 2983525
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma.
Nagatani T; Miyazawa M; Matsuzaki T; Iemoto G; Kim ST; Baba N; Miyamoto H; Nakajima H
Semin Dermatol; 1994 Sep; 13(3):216-22. PubMed ID: 7986691
[TBL] [Abstract][Full Text] [Related]
11. Large-cell transformation following detection of minimal residual disease in cutaneous T-cell lymphoma: molecular and in situ analysis of a single neoplastic T-cell clone expressing the identical T-cell receptor.
Wolfe JT; Chooback L; Finn DT; Jaworsky C; Rook AH; Lessin SR
J Clin Oncol; 1995 Jul; 13(7):1751-7. PubMed ID: 7602365
[TBL] [Abstract][Full Text] [Related]
12. The immunoarchitecture of cutaneous pseudolymphoma.
Wirt DP; Grogan TM; Jolley CS; Rangel CS; Payne CM; Hansen RC; Lynch PJ; Schuchardt M
Hum Pathol; 1985 May; 16(5):492-510. PubMed ID: 3157635
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of cutaneous T cell lymphoma by use of monoclonal antibodies reactive with tumor-associated antigens.
Berger CL; Morrison S; Chu A; Patterson J; Estabrook A; Takezaki S; Sharon J; Warburton D; Irigoyen O; Edelson RL
J Clin Invest; 1982 Dec; 70(6):1205-15. PubMed ID: 6217214
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of p53 protein in cutaneous T cell lymphoma: relationship to large cell transformation and disease progression.
Li G; Chooback L; Wolfe JT; Rook AH; Felix CA; Lessin SR; Salhany KE
J Invest Dermatol; 1998 May; 110(5):767-70. PubMed ID: 9579543
[TBL] [Abstract][Full Text] [Related]
15. Monomorphic lymphomas arising in patients with Hodgkin's disease. Correlation of morphologic, immunophenotypic, and molecular genetic findings in 12 cases.
Casey TT; Cousar JB; Mangum M; Williams ME; Lee JT; Greer JP; Collins RD
Am J Pathol; 1990 Jan; 136(1):81-94. PubMed ID: 2297052
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous T cell lymphoma with suppressor phenotype and function.
Salmeron G; Hillman N; Paul CC; Taylor CA; Schroeter A; Baumann MA
South Med J; 1989 Apr; 82(4):520-4. PubMed ID: 2523089
[TBL] [Abstract][Full Text] [Related]
17. Cytologic transformation in cutaneous T cell lymphoma: a clinicopathologic entity associated with poor prognosis.
Dmitrovsky E; Matthews MJ; Bunn PA; Schechter GP; Makuch RW; Winkler CF; Eddy J; Sausville EA; Ihde DC
J Clin Oncol; 1987 Feb; 5(2):208-15. PubMed ID: 3492594
[TBL] [Abstract][Full Text] [Related]
18. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
Bosisio FM; Cerroni L
Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of immunologic phenotyping in cutaneous T cell lymphoma.
Vonderheid EC; Tan E; Sobel EL; Schwab E; Micaily B; Jegasothy BV
J Am Acad Dermatol; 1987 Jul; 17(1):40-52. PubMed ID: 2956298
[TBL] [Abstract][Full Text] [Related]
20. Primary and secondary cutaneous Ki-1+ (CD30+) anaplastic large cell lymphomas. Morphologic, immunohistologic, and clinical-characteristics.
Kaudewitz P; Stein H; Dallenbach F; Eckert F; Bieber K; Burg G; Braun-Falco O
Am J Pathol; 1989 Aug; 135(2):359-67. PubMed ID: 2551170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
